Xeljanz Injury Attorneys in Texas and New Mexico
The U.S. Food and Drug Administration initially approved the Pfizer manufactured Xeljanz in 2012 to treat moderately to severely active rheumatoid arthritis. Later, it was approved to treat psoriatic arthritis and ulcerative colitis.
In early 2019, the FDA released a safety alert regarding an increased risk of blood clots and death with the medication’s use.
Since then, the federal agency has approved a black box warning, which is required when certain medications carry serious safety risks.
The considerable safety risks associated with Xeljanz may include blood clots, cardiovascular problems, cancer, or death.
If you or someone you love has used Xeljanz and suffered injuries or lost their life because of its use, contact our knowledgeable Xeljanz attorneys in New Mexico and Texas today to discuss your legal rights to pursue the manufacturer for financial recovery.
What Types of Blood Clots are Linked to Xeljanz Use in Texas and New Mexico?
The most-reported blood clots suffered by Xeljanz users include pulmonary embolisms and deep vein thrombosis.
Pulmonary embolisms, or PEs, are dangerous blood clots that travel to the lungs and can cause irregular heartbeat, chest pain, and trouble breathing.
Deep Vein Thrombosis, or DVTs, may cause pain, swelling, tenderness, and redness in the part of the body where the blood clot formed or traveled.
Both types of blood clots can be life-threatening and require immediate medical attention.
Lawsuits against Pfizer may seek compensation for medical bills incurred from DVT or PE treatment.
What Types of Cardiovascular Problems are Linked to Xeljanz Use in Texas and New Mexico?
The FDA linked Xeljanz to an increased risk of serious cardiovascular events that may include:
- Cardiac arrest
- Cardiovascular death
- Congestive heart failure
- Coronary revascularization
- Myocardial infarction
If you or someone you love has suffered serious cardiac health problems from using Xeljanz, contact our experienced personal injury lawyers in Texas and New Mexico today for a free consultation.
What Types of Cancers are Linked to Xeljanz Use in Texas and New Mexico?
The black box warning that accompanies Xeljanz warns users about an increased risk of lymphoma and other cancers.
Cancers linked to Xeljanz use include:
- Lung Cancer
- Breast Cancer
- Colon Cancer
- Non-Hodgkin’s Lymphoma
- Prostate Cancer
If your health has been adversely affected by Xeljanz use, contact our experienced personal injury lawyers at the Ruhmann Law Firm in Texas at 915-845-4529, New Mexico at 575-526-4529, or online to discuss your case during a free consultation. We are here to help provide you with the legal representation you need to pursue the manufacturer for the financial compensation you deserve.